Influence of cognitive reserve in schizophrenia: A systematic review.


Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
01 2020
Historique:
received: 10 06 2019
revised: 10 10 2019
accepted: 26 10 2019
pubmed: 7 11 2019
medline: 29 12 2020
entrez: 6 11 2019
Statut: ppublish

Résumé

To perform a systematic review of the influence of sociobehavioural indicators of cognitive reserve (CR) in the risk of schizophrenia, the clinical manifestations of the disease, and cognitive intervention programs (CRT) carried out with these patients. A cross search was made by two independent reviewers in Pubmed and PsycINFO databases using keywords "schizophrenia" and "cognitive reserve." Twenty-one studies which analyzed different CR proxies were selected and the level of evidence was classified according to the Oxford Centre for Evidence-Based Medicine. People with higher CR may have a lower risk of developing schizophrenia and a later onset of disease. In addition, they present better neuropsychological and functional performance in the illness course. However, the suspected influence of CR on the effectiveness of CRT in patients with schizophrenia is currently unresolved. Our findings suggest that higher CR delays the clinical diagnosis threshold and severity of the symptoms in patients with schizophrenia. However, effect of singular sociobehavioral measures on clinical expression and benefits of intervention program need further investigation.

Identifiants

pubmed: 31689453
pii: S0149-7634(19)30481-6
doi: 10.1016/j.neubiorev.2019.10.019
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-159

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Paula Herrero (P)

Psychiatric Institute José Germain, Madrid, Spain.

Israel Contador (I)

Department of Basic Psychology, Psychobiology and Methodology of Behavioral Sciences, Faculty of Psychology, University of Salamanca, Spain. Electronic address: icontador@usal.es.

Yaakov Stern (Y)

Departments of Neurology, Psychiatry, and Psychology, and the Taub Institute for the Research on Alzheimer's Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, New York, United States.

Bernardino Fernández-Calvo (B)

Department of Psychology, Federal University of Paraíba, Brazil.

Abraham Sánchez (A)

Department of Basic Psychology, Psychobiology and Methodology of Behavioral Sciences, Faculty of Psychology, University of Salamanca, Spain.

Francisco Ramos (F)

Department of Personality, Assessment and Psychological Treatment, Faculty of Psychology, University of Salamanca, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH